Published in
Wiley, Alimentary Pharmacology and Therapeutics, 11(47), p. 1551-1552
DOI: 10.1111/apt.14649
Links
Tools
Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients
Journal article published in 2018 by
P. Ingiliz 
,
A. Canbay
,
A. Canbay
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 